Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$479M |
| 2 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$415M |
| 3 |
Apple
AAPL
|
+$313M |
| 4 |
State Street SPDR Portfolio Intermediate Term Treasury ETF
SPTI
|
+$292M |
| 5 |
JPMorgan Chase
JPM
|
+$282M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$393M |
| 2 |
American Tower
AMT
|
+$282M |
| 3 |
Wells Fargo
WFC
|
+$268M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$241M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$236M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.56% |
| 2 | Healthcare | 12.1% |
| 3 | Financials | 10.73% |
| 4 | Consumer Discretionary | 8.24% |
| 5 | Industrials | 7.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Standard BioTools
LAB
$342M
| $42K | ﹤0.01% |
+10,605
| New | +$36.9K |
|
3577
Mizuho Financial
MFG
$120B
| $42K | ﹤0.01% |
17,150
-17,604
| -51% | -$41.8K |
|
3578
IAMGOLD
IAG
$8.05B
| $40K | ﹤0.01% |
10,000
| – | – |
|
|
DRRX
3579
DELISTED
DURECT Corp
DRRX
| $39K | ﹤0.01% |
1,681
| – | – |
|
|
SNT
3580
Senstar Technologies
SNT
$39.2M
| $39K | ﹤0.01% |
13,000
-5,000
| -28% | -$14.8K |
|
|
EMKR
3581
DELISTED
Emcore Corp
EMKR
| $39K | ﹤0.01% |
1,218
| – | – |
|
3582
Pixelworks
PXLW
$37.2M
| $38K | ﹤0.01% |
988
+11
| +1% | +$476 |
|
|
PR
3583
Permian Resources
PR
$17.4B
| $37K | ﹤0.01% |
41,594
-9,271
| -18% | -$8.15K |
|
3584
Verastem
VSTM
$528M
| $32K | ﹤0.01% |
1,534
+33
| +2% | +$873 |
|
3585
Savara
SVRA
$1.08B
| $30K | ﹤0.01% |
+12,256
| New | +$29.8K |
|
|
TLRD
3586
DELISTED
Tailored Brands, Inc.
TLRD
| $30K | ﹤0.01% |
32,089
-338,303
| -91% | -$448K |
|
|
ENLC
3587
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $29K | ﹤0.01% |
11,916
-2,042
| -15% | -$4.22K |
|
3588
Tenax Therapeutics
TENX
$393M
| $27K | ﹤0.01% |
+19
| New | +$27.9K |
|
|
OGI
3589
Organigram Holdings
OGI
$131M
| $26K | ﹤0.01% |
4,092
+1,299
| +47% | +$8.75K |
|
|
MRNS
3590
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $26K | ﹤0.01% |
2,550
-51
| -2% | -$469 |
|
|
ELVT
3591
DELISTED
Elevate Credit, Inc.
ELVT
| $25K | ﹤0.01% |
17,085
| – | – |
|
|
HTZ
3592
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $24K | ﹤0.01% |
16,892
-323,145
| -95% | -$1.03M |
|
3593
Marchex
MCHX
$78M
| $21K | ﹤0.01% |
13,192
-500
| -4% | -$757 |
|
|
PLM
3594
DELISTED
PolyMet Mining Corp.
PLM
| $21K | ﹤0.01% |
5,272
+337
| +7% | +$976 |
|
|
WLL
3595
DELISTED
Whiting Petroleum Corporation
WLL
| $19K | ﹤0.01% |
226
-5,829
| -96% | -$454K |
|
3596
McEwen Inc
MUX
$1B
| $16K | ﹤0.01% |
1,540
| – | – |
|
|
VIVS
3597
VivoSim Labs
VIVS
$1.21M
| $16K | ﹤0.01% |
+124
| New | +$15.1K |
|
3598
Kopin
KOPN
$586M
| $15K | ﹤0.01% |
+11,000
| New | +$9.21K |
|
|
INFI
3599
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $15K | ﹤0.01% |
16,400
+2,300
| +16% | +$2.19K |
|
3600
SandRidge Energy
SD
$503M
| $14K | ﹤0.01% |
+10,702
| New | +$16.1K |
|
Similar funds
Ameriprise's Q2 2020 Portfolio in Review
As of Q2 2020, Ameriprise held 3,808 positions worth $233B, up 23% from $190B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ameriprise's Q2 2020 filing shows 183 new, 1,548 increased, 1,847 reduced and 139 closed positions. Its largest new stake was Carrier Global: 9,308,867 shares worth $207M. The largest sale was Verizon, an estimated $393M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q2 2020 buy was Carrier Global: 9,308,867 shares worth $207M.
- Ameriprise added most to TE Connectivity in Q2 2020, an estimated $479M increase.
- Ameriprise's biggest Q2 2020 reduction was Verizon, cutting an estimated $393M.
- Ameriprise fully exited Allergan plc in Q2 2020, selling an estimated $124M.
- Ameriprise's ten largest holdings make up 17% of its $233B portfolio in Q2 2020.
- Ameriprise opened 183 new positions and closed 139 in Q2 2020.
- Ameriprise's portfolio value rose 23% quarter-over-quarter to $233B.
Based on Ameriprise's 13F filing for Q2 2020, filed 14 Aug 2020.